Plasma - Activated medium engages redox signaling to activate a VDAC1-TRPML1 lysosomal-mitochondrial Ca2+ death

Pengpeng Huang1, Yan Zheng2, Chuanzan Zhou3

  • 1School of Nuclear Science and Technology, University of Science and Technology of China, Hefei, Anhui, China; Institute of Advanced Technology, University of Science and Technology of China, Hefei, Anhui, China.

Insights

Plasma-activated medium (PAM) triggers cancer cell death by disrupting calcium flow between lysosomes and mitochondria. This involves the VDAC1-TRPML1 axis, offering a potential therapeutic target and biomarker for cancer treatment.

Area of Science:

  • Oncology
  • Cell Biology
  • Biochemistry

Background:

  • Plasma-activated medium (PAM) is a redox-based anticancer therapy with unclear mechanisms of tumor cell death.
  • Understanding PAM's action is crucial for optimizing its therapeutic potential.

Purpose of the Study:

  • To elucidate the molecular mechanisms of PAM-induced tumor cell death.
  • To identify key molecular players and pathways involved in PAM cytotoxicity.
  • To explore the VDAC1-TRPML1 axis as a potential therapeutic target and biomarker.

Main Methods:

  • Utilized A549 lung cancer cells and other tumor models.
  • Investigated organelle contact sites and calcium (Ca2+) flux between lysosomes and mitochondria.
  • Analyzed signaling pathways including mTORC2-SGK1 and VDAC1 phosphorylation.
  • Performed in vivo studies and pan-cancer analyses.

Main Results:

  • Identified a lysosome-mitochondria Ca2+ circuit critical for PAM-induced cell death.
  • PAM promotes VDAC1-TRPML1 coupling, leading to lysosomal Ca2+ release and mitochondrial Ca2+ overload.
  • PAM suppresses mTORC2-SGK1 signaling, stabilizing VDAC1 and enhancing pathological Ca2+ transfer.
  • Disrupting the VDAC1-TRPML1 interaction or VDAC1 phosphorylation attenuated PAM's antitumor effects.
  • High VDAC1 expression may predict tumor response to PAM.

Conclusions:

  • The VDAC1-TRPML1 axis is a key mediator of PAM-induced, lysosome-mitochondria Ca2+-dependent tumor cell death.
  • This pathway represents a novel therapeutic target and a potential biomarker for stratifying tumors for PAM therapy.
  • Findings advance the understanding of redox-based cancer therapies and cell death mechanisms.

Related Concept Videos

The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Autophagic Cell Death01:18

Autophagic Cell Death

Christian de Duve discovered “autophagy,” a process in which cellular components are engulfed by membrane-bound organelles called autophagosomes. The autophagosomes then fuse with lysosomes to digest the enclosed contents. Autophagy is generally activated in cells to prevent cell death. However, cell death is triggered when the damage is beyond repair.
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and pro-apoptotic...
Apoptosis01:30

Apoptosis

Apoptosis is a combination of two Greek words, 'apo' and 'ptosis,' meaning separation and falling off, respectively. Hippocrates used this word to describe gangrene, which was caused due to bandaging of fractured bones. Apoptosis was distinguished from necrosis in 1970 when John Kerr reported observations of morphological changes occurring during apoptosis. During one experiment, he observed that the disruption of blood supply to the liver tissue resulted in a size reduction of the tissue.
Necrosis01:16

Necrosis

Necrosis is considered as an “accidental” or unexpected form of cell death that ends in cell lysis. The first noticeable mention of “necrosis” was in 1859 when Rudolf Virchow used this term to describe advanced tissue breakdown in his compilation titled “Cell Pathology”.
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become anucleated and die, but their...
Overview of Cell Death01:30

Overview of Cell Death

Cell death is an essential process where the body gets rid of old or damaged cells. Cell proliferation and death need to be balanced, as an imbalance between the two may lead to cancer or autoimmune diseases.
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the 20th century...